ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1267

Blood Pressure Control over Time in Childhood-Onset Systemic Lupus Erythematous

Pinar Ozge Avar Aydin1, Jian Shan2, Hermine I. Brunner1 and Mark Mitsnefes3, 1Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Peking Union Medical College Hospital, Peking, China, Peking, China, 3Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, hypertension, lupus nephritis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster II: Lupus and Related Disorders, Myositis, Scleroderma and Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiovascular disease (CVD) is the leading cause of increased long-term morbidity and mortality in systemic lupus erythematosus (SLE). As an important modifiable risk factor for CVD, hypertension (HTN) is prevalent in patients with SLE and causes early cardiovascular aging and progression of the renal and cardiac disease. The aims of this longitudinal retrospective study were to determine the prevalence of HTN, evaluate longitudinal trend in blood pressure control, and assess risk factors for HTN in childhood-onset SLE (cSLE).

Methods: Between January 2012 and December 2016, demographic and clinical data of consecutive visits including sitting blood pressure, disease activity as measured by the SLE disease activity index (SLEDAI), presence of lupus nephritis, medication use, and results of the standard laboratory testing from cSLE diagnosis to the last visit were extracted from medical records of patients with cSLE admitted to the rheumatology clinic.

Results: 110 patients with cSLE were recruited: 79% female; 35% blacks; mean age at the baseline visit 13.3 ± 3.0 years; median follow-up duration 29.5 months; 19% had lupus nephritis. Twenty-nine percent of patients had HTN and 23% had pre-hypertension at the baseline visit. Patients with HTN had higher disease activity, more frequent renal involvement, lower eGFR, and were more obese than patients without HTN. In the multivariate analysis, the presence of nephritis, obesity, and high extra-renal disease activity (SLEDAI score ≥ 10) were independent predictors of HTN at the baseline. No significant changes in blood pressure control were observed in patients without nephritis. Patients with nephritis had less stage 1 and 2 HTN, and more prehypertension at the last follow-up compared to the baseline.

Conclusion: While hypertension is known feature of lupus nephritis, our results indicate that hypertension is common and persistent in cSLE without kidney disease with about one third of patients having uncontrolled elevated BP almost 3 years after onset of lupus. In addition to renal disease, obesity and high overall disease activity were identified as independent predictors of HTN in these patients.


Disclosure: P. O. Avar Aydin, None; J. Shan, None; H. I. Brunner, None; M. Mitsnefes, None.

To cite this abstract in AMA style:

Avar Aydin PO, Shan J, Brunner HI, Mitsnefes M. Blood Pressure Control over Time in Childhood-Onset Systemic Lupus Erythematous [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/blood-pressure-control-over-time-in-childhood-onset-systemic-lupus-erythematous/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blood-pressure-control-over-time-in-childhood-onset-systemic-lupus-erythematous/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology